FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894951270> ?p ?o ?g. }

• W2894951270 endingPage "725" @default.
• W2894951270 startingPage "720" @default.
• W2894951270 abstract "Bortezomib (BTZ) is one of the most frequently used drugs in treatment of multiple myeloma (MM), but drug-resistance often occurs and limits its clinical efficacy. Annexin A1 (ANXA1) is upregulated in MM, and its knockdown enhances chemosensitivity in MM. However, whether ANXA1 inhibition can increase antitumor activity of BTZ in MM cells remains unknown. In the present study, Cell Counting Kit-8 (CCK-8) and colony formation assays showed that ANXA1 silencing combined with BTZ treatment led to a more significant inhibition of MM cell proliferation than each treatment alone. Cell apoptosis was dramatically promoted in MM cells following silencing of ANXA1 and BTZ administration versus that in ANXA1-silenced alone or BTZ-treated alone cells, as evidenced by decreased expression of phosphorylated signal transducers and activators of transcription 3 and BCL2, and increased expression of BAX. Moreover, we demonstrated that the levels of IL-6 and IL-23 were markedly downregulated in ANXA1-silenced and BTZ-treated MM cells. Furthermore, the combination of ANXA1 knockdown and BTZ treatment distinctly suppressed tumor growth in vivo compared with BTZ treatment alone. Taken together, our results show that downregulation of ANXA1 enhances antitumor activity of BTZ in MM in vitro and in vivo, indicating that ANXA1 may be a promising target for enhancing the chemosensitivity of MM to BTZ." @default.
• W2894951270 created "2018-10-12" @default.
• W2894951270 creator A5000128016 @default.
• W2894951270 creator A5026563375 @default.
• W2894951270 creator A5067811229 @default.
• W2894951270 creator A5070316994 @default.
• W2894951270 creator A5087177621 @default.
• W2894951270 date "2018-11-01" @default.
• W2894951270 modified "2023-09-26" @default.
• W2894951270 title "Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo" @default.
• W2894951270 cites W1549078051 @default.
• W2894951270 cites W1566207114 @default.
• W2894951270 cites W1929646883 @default.
• W2894951270 cites W1972239602 @default.
• W2894951270 cites W1975216874 @default.
• W2894951270 cites W1980871234 @default.
• W2894951270 cites W1992467867 @default.
• W2894951270 cites W2000989019 @default.
• W2894951270 cites W2006379003 @default.
• W2894951270 cites W2018086925 @default.
• W2894951270 cites W2023997697 @default.
• W2894951270 cites W2044227662 @default.
• W2894951270 cites W2046020700 @default.
• W2894951270 cites W2059075557 @default.
• W2894951270 cites W2069702666 @default.
• W2894951270 cites W2082015682 @default.
• W2894951270 cites W2086416870 @default.
• W2894951270 cites W2094565648 @default.
• W2894951270 cites W2096553204 @default.
• W2894951270 cites W2123470080 @default.
• W2894951270 cites W2127193407 @default.
• W2894951270 cites W2137210293 @default.
• W2894951270 cites W2139237787 @default.
• W2894951270 cites W2142793991 @default.
• W2894951270 cites W2146162030 @default.
• W2894951270 cites W2150532545 @default.
• W2894951270 cites W2154290057 @default.
• W2894951270 cites W2156088719 @default.
• W2894951270 cites W2286968366 @default.
• W2894951270 cites W2494644907 @default.
• W2894951270 cites W2740828344 @default.
• W2894951270 doi "https://doi.org/10.1016/j.bbrc.2018.09.140" @default.
• W2894951270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30292410" @default.
• W2894951270 hasPublicationYear "2018" @default.
• W2894951270 type Work @default.
• W2894951270 sameAs 2894951270 @default.
• W2894951270 citedByCount "10" @default.
• W2894951270 countsByYear W28949512702019 @default.
• W2894951270 countsByYear W28949512702020 @default.
• W2894951270 countsByYear W28949512702021 @default.
• W2894951270 countsByYear W28949512702022 @default.
• W2894951270 crossrefType "journal-article" @default.
• W2894951270 hasAuthorship W2894951270A5000128016 @default.
• W2894951270 hasAuthorship W2894951270A5026563375 @default.
• W2894951270 hasAuthorship W2894951270A5067811229 @default.
• W2894951270 hasAuthorship W2894951270A5070316994 @default.
• W2894951270 hasAuthorship W2894951270A5087177621 @default.
• W2894951270 hasConcept C104317684 @default.
• W2894951270 hasConcept C119056186 @default.
• W2894951270 hasConcept C127561419 @default.
• W2894951270 hasConcept C150903083 @default.
• W2894951270 hasConcept C173396325 @default.
• W2894951270 hasConcept C185592680 @default.
• W2894951270 hasConcept C190283241 @default.
• W2894951270 hasConcept C202751555 @default.
• W2894951270 hasConcept C203014093 @default.
• W2894951270 hasConcept C207001950 @default.
• W2894951270 hasConcept C2776364478 @default.
• W2894951270 hasConcept C2777478702 @default.
• W2894951270 hasConcept C502942594 @default.
• W2894951270 hasConcept C54355233 @default.
• W2894951270 hasConcept C55493867 @default.
• W2894951270 hasConcept C62112901 @default.
• W2894951270 hasConcept C68246026 @default.
• W2894951270 hasConcept C71924100 @default.
• W2894951270 hasConcept C81885089 @default.
• W2894951270 hasConcept C86803240 @default.
• W2894951270 hasConcept C88634738 @default.
• W2894951270 hasConcept C98274493 @default.
• W2894951270 hasConceptScore W2894951270C104317684 @default.
• W2894951270 hasConceptScore W2894951270C119056186 @default.
• W2894951270 hasConceptScore W2894951270C127561419 @default.
• W2894951270 hasConceptScore W2894951270C150903083 @default.
• W2894951270 hasConceptScore W2894951270C173396325 @default.
• W2894951270 hasConceptScore W2894951270C185592680 @default.
• W2894951270 hasConceptScore W2894951270C190283241 @default.
• W2894951270 hasConceptScore W2894951270C202751555 @default.
• W2894951270 hasConceptScore W2894951270C203014093 @default.
• W2894951270 hasConceptScore W2894951270C207001950 @default.
• W2894951270 hasConceptScore W2894951270C2776364478 @default.
• W2894951270 hasConceptScore W2894951270C2777478702 @default.
• W2894951270 hasConceptScore W2894951270C502942594 @default.
• W2894951270 hasConceptScore W2894951270C54355233 @default.
• W2894951270 hasConceptScore W2894951270C55493867 @default.
• W2894951270 hasConceptScore W2894951270C62112901 @default.
• W2894951270 hasConceptScore W2894951270C68246026 @default.
• W2894951270 hasConceptScore W2894951270C71924100 @default.
• W2894951270 hasConceptScore W2894951270C81885089 @default.

• next